Table 2.
DALYs per the selected diseases at the global level and the number of prioritisation exercises conducted for them⁎
Disease | Source | DALYs | Result from the prioritization |
---|---|---|---|
Toxoplasmosis, acquired | FERG⁎⁎ | 153,779 (772676–1,733,114) |
7 |
Cystic echinococcosis | FERG⁎⁎ | 183,573 (88082–1590 46) |
9 |
Brucellosis | FERG⁎⁎ | 264,073 (100540–6,187,148) |
75 |
Toxoplasmosis, congenital | FERG⁎⁎ | 526,515 (359756–835,537) |
7 |
TB bovine | FERG⁎⁎ | 607,775 (458364–826,115) |
47 |
Alveolar echinococcosis | FERG⁎⁎ | 687,823 (409190–1,106,320) |
9 |
Foodborne trematodiasis | FERG⁎⁎ | 2,024,592 (1652243–2,483,514) |
– |
Cysticercosis | FERG⁎⁎ | 2,788,426 (213763–3,606,582) |
9 |
Campylobacteriosis | FERG⁎⁎ | 3,733,822 (2857037–5,273,652) |
5 |
Non-typhoidal salmonellosis | FERG⁎⁎ | 4,377,930 (3242020–7,175,522) |
25 |
African trypanosomiasis | GBD | 82,615 (37636–155,791) |
9 |
Cystic echinococcosis | GBD | 122,457 (89244–168,556) |
9 |
Ebola | GBD | 195,394 (230578–160,083) |
20 |
Yellow fever | GBD | 290,137 (107073–597,713) |
11 |
Leishmaniosis | GBD | 696,703 (375207–1,619,382) |
5 |
Foodborne trematodiasis | GBD | 780,089 (385735–1,446,031) |
– |
Rabies | GBD | 782,052 (320289–1,081,217) |
94 |
Cysticercosis | GBD | 1,371,067 (874432–1,960,855) |
7 |
Non-typhoidal salmonellosis (invasive) | GBD | 6,114,262 (3323425–9,705,738) |
25 |
Rift Valley Fever | Labeaud et al. (2011) | 6156 (353–11,958) |
28 |
Japanese encephalitis | Labeaud et al. (2011) | 1,062,474 (265778–1,859,170) |
8 |
Leptospirosis | Torgerson et al. (2015) | 2,900,000 (1250000–4,540,000) |
20 |
This table only provides an overview of the different global estimates; it is important to note that they are not directly comparable since they come from different sources that applied different methodologies (as is visible, for example, from the estimates of non-typhoidal salmonella, for more information see [55]).
For FERG, the estimates are reported by all transmission routes, not just foodborne.